139 related articles for article (PubMed ID: 2888108)
1. The positive-negative dimension in schizophrenia: its validity and significance.
Kay SR; Opler LA
Psychiatr Dev; 1987; 5(2):79-103. PubMed ID: 2888108
[TBL] [Abstract][Full Text] [Related]
2. [Hypofrontality and negative symptoms in schizophrenia: synthesis of anatomic and neuropsychological knowledge and ecological perspectives].
Semkovska M; Bédard MA; Stip E
Encephale; 2001; 27(5):405-15. PubMed ID: 11760690
[TBL] [Abstract][Full Text] [Related]
3. [Incidence of the deficit form in refractory schizophrenia].
Samuelian JC
Encephale; 1996 Jun; 22 Spec No 2():19-23. PubMed ID: 8767037
[TBL] [Abstract][Full Text] [Related]
4. [A four-dimensional model of chronic schizophrenia based on the factorial structure of the Positive and Negative Syndrome Scale (PANSS). A study of a group of 153 chronic schizophrenic patients and comparison with the factorial structure of the BPRS].
Loas G; Noisette C; Legrand A; Delahousse J
Encephale; 1997; 23(1):10-8. PubMed ID: 9172962
[TBL] [Abstract][Full Text] [Related]
5. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
[TBL] [Abstract][Full Text] [Related]
6. Deficit in schizophrenia: the relationship between negative symptoms and neurocognition.
Penadés R; Gastó C; Boget T; Catalán R; Salamero M
Compr Psychiatry; 2001; 42(1):64-9. PubMed ID: 11154718
[TBL] [Abstract][Full Text] [Related]
7. Predictive validity of proposed remission criteria in first-episode schizophrenic patients responding to antipsychotics.
Wunderink L; Nienhuis FJ; Sytema S; Wiersma D
Schizophr Bull; 2007 May; 33(3):792-6. PubMed ID: 16894026
[TBL] [Abstract][Full Text] [Related]
8. [Schedule for evaluation of the deficit syndrome in schizophrenia: Schedule for Deficit Syndrome (SDS) (Kirkpatrick et al.). Importance pertinence of the SDS. Introduction of the French version].
Ribeyre JM; Dollfus S; Lesieur P; Ménard JF; Petit M
Encephale; 1994; 20(4):413-9. PubMed ID: 7988405
[TBL] [Abstract][Full Text] [Related]
9. [Core factors of schizophrenia structure based on PANSS and SAPS/SANS results. Discerning and head-to-head comparisson of PANSS and SASPS/SANS validity].
Masiak M; Loza B
Psychiatr Pol; 2004; 38(5):795-808. PubMed ID: 15523927
[TBL] [Abstract][Full Text] [Related]
10. The psychopathology of schizophrenia: an integrated view on positive symptoms and negative symptoms.
Möller HJ
Int Clin Psychopharmacol; 1995 Sep; 10 Suppl 3():57-64. PubMed ID: 8866766
[TBL] [Abstract][Full Text] [Related]
11. [Comparison of 2 depression scales and their relationship with negative and akinetic symptoms in stabilized schizophrenic patients].
Langlois-Thery S; Dollfus S; Lesieur P; Petit M
Encephale; 1994; 20(5):487-93. PubMed ID: 7828511
[TBL] [Abstract][Full Text] [Related]
12. [Deficit: the value and difficulty of defining the primary or secondary character of observed symptoms].
Petit M; Langlois S
Encephale; 1996 Jun; 22 Spec No 2():13-8. PubMed ID: 8767036
[TBL] [Abstract][Full Text] [Related]
13. The relationship between insight and symptoms in schizophrenia.
Sevy S; Nathanson K; Visweswaraiah H; Amador X
Compr Psychiatry; 2004; 45(1):16-9. PubMed ID: 14671732
[TBL] [Abstract][Full Text] [Related]
14. Relative contribution of antipsychotics, negative symptoms and executive functions to social functioning in stable schizophrenia.
Rocca P; Montemagni C; Castagna F; Giugiario M; Scalese M; Bogetto F
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Mar; 33(2):373-9. PubMed ID: 19211031
[TBL] [Abstract][Full Text] [Related]
15. [New aspects in the diagnosis, pathogenesis and therapy of schizophrenic negative symptoms].
Müller-Spahn F; Modell S; Thomma M
Nervenarzt; 1992 Jul; 63(7):383-400. PubMed ID: 1354331
[TBL] [Abstract][Full Text] [Related]
16. Comparative analysis of soft neurological signs in positive and negative subtype of schizophrenia.
Cvetić T; Vuković O; Britvić D; Ivković M; Dukić-Dejanović S; Lecić-Tosevski D
Psychiatr Danub; 2009 Jun; 21(2):174-8. PubMed ID: 19556945
[TBL] [Abstract][Full Text] [Related]
17. Premorbid functioning, cognitive functioning, symptoms and outcome in schizophrenia.
Addington J; Addington D
J Psychiatry Neurosci; 1993 Jan; 18(1):18-23. PubMed ID: 8461276
[TBL] [Abstract][Full Text] [Related]
18. [Validation of positive and negative symptom scale (PANSS) in a sample of Spanish schizophrenic patients].
Peralta Martín V; Cuesta Zorita MJ
Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1994; 22(4):171-7. PubMed ID: 7810373
[TBL] [Abstract][Full Text] [Related]
19. Revisiting the 5 dimensions of the Positive and Negative Syndrome Scale.
Levine SZ; Rabinowitz J
J Clin Psychopharmacol; 2007 Oct; 27(5):431-6. PubMed ID: 17873671
[TBL] [Abstract][Full Text] [Related]
20. Predicting medication-free treatment response in acute psychosis: cross-validation from the Finnish Need-Adapted Project.
Bola JR; Lehtinen K; Aaltonen J; Räkköläinen V; Syvälahti E; Lehtinen V
J Nerv Ment Dis; 2006 Oct; 194(10):732-9. PubMed ID: 17041284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
